Literature DB >> 7981507

Hirschsprung's disease--immunohistochemical findings.

L T Larsson1.   

Abstract

Hirschsprung's disease (HSCR) is characterized by a non-propulsive distal intestinal segment (usually colon) leading to a functional obstruction. An absence of ganglia in the affected segment explains the synonymous term "aganglionosis coli". The lack of peristalsis is partly due to a deficient intestinal smooth muscle relaxation based on an absence of non-adrenergic, non-cholinergic (NANC) inhibitory innervation. Morphological studies using conventional microscopy, immunohistochemistry and immunochemistry against general neuronal markers and neuropeptides have been used to characterize the disturbed NANC innervation in HSCR. An increased cholinergic and adrenergic innervation is registered in the aganglionic segment in spite of the lack of neuronal cell bodies: Neuropeptides like vasoactive intestinal peptide (VIP), pituitary adenylate cyclase-activating polypeptide (PACAP), gastrin-releasing peptide (GRP), calcitonin gene-related peptide (CGRP), substance P (SP), enkephalins and galanin immunoreactive nerve fibres are all reduced in number in the aganglionic segment. In contrast, neuropeptide Y (NPY)-containing nerve fibres are increased in number in the diseased segment, probably reflecting the adrenergic hyperinnervation. General neuronal markers including chromogranins have been used to map the neuronal network in the HSCR intestine and also to investigate the endocrine cell system in the intestinal mucosa. Nitric oxide is a potent component of the NANC inhibitory innervation and its synthesizing enzyme, nitric oxide synthase (NOS), is shown to be almost absent in the neuronal system in aganglionic intestine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7981507

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  7 in total

1.  Distribution of nitric oxide synthase-containing nerves in the aganglionic intestine of mutant rats: a histochemical study.

Authors:  M Teramoto; T Domoto; K Tanigawa; Y Yasui; K Tamura
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

2.  Peptidergic innervation of the internal anal sphincter in Hirschsprung's disease.

Authors:  B Husberg; M Schultzberg
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827

3.  Loss of visceral pain following colorectal distension in an endothelin-3 deficient mouse model of Hirschsprung's disease.

Authors:  Vladimir P Zagorodnyuk; Melinda Kyloh; Sarah Nicholas; Heshan Peiris; Simon J Brookes; Bao Nan Chen; Nick J Spencer
Journal:  J Physiol       Date:  2011-02-14       Impact factor: 5.182

4.  The loss of calretinin expression indicates aganglionosis in Hirschsprung's disease.

Authors:  I Barshack; E Fridman; I Goldberg; Y Chowers; J Kopolovic
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

5.  Nitric oxide synthase and VIP distribution in enteric nervous system in idiopathic chronic constipation.

Authors:  C Cortesini; F Cianchi; A Infantino; M Lise
Journal:  Dig Dis Sci       Date:  1995-11       Impact factor: 3.199

Review 6.  Purinergic signalling in the gastrointestinal tract and related organs in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-12-04       Impact factor: 3.765

7.  Gastrointestinal dysfunction in mice with a targeted mutation in the gene encoding vasoactive intestinal polypeptide: a model for the study of intestinal ileus and Hirschsprung's disease.

Authors:  V Lelievre; G Favrais; C Abad; H Adle-Biassette; Y Lu; P M Germano; G Cheung-Lau; J R Pisegna; P Gressens; G Lawson; J A Waschek
Journal:  Peptides       Date:  2007-05-18       Impact factor: 3.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.